Ad-hoc announcement according to Art. 17 (1) MAR Media contact Steffen Rinas T +49 6172 608-6698 steffen.rinas@fresenius.com Contact for analysts and investors Dr. Dominik Heger T +49 6172 609-2601 dominik.heger@fmc-ag.c

Fresenius Medical Care AG & Co.

KGaA: Ms. Helen Giza appointed as new CEO of the Management Board; Dr. Carla Kriwet agreed to resign as CEO and member of the

Today, the Supervisory Board of Fresenius Medical

Care Management AG, the General Partner of Fresenius Medical Care AG & Co. KGaA, has unanimously appointed Ms. Helen Giza

as CEO of the Management Board with effect as of the beginning of December 6, 2022. Ms. Helen Giza remains also acting Chief

Financial Officer of Fresenius Medical Care until a successor has been found. In addition, the Supervisory Board of Fresenius Medical

Care Management AG has accepted the offer by Dr. Carla Kriwet to resign as CEO and member of the Management Board with effect as

of the end of December 5, 2022 before.

In her capacity as CEO of Fresenius Medical Care,

Ms. Helen Giza will also be a member of the Management Board of Fresenius Management SE. Dr. Carla Kriwet also has resigned

as a member of the Management Board of Fresenius Management SE.

EVP Head of Investor Relations, Strategic Development & Communications

P. +49 6172 609 2601